Literature DB >> 3372017

Emergence in gnotobiotic mice of nontoxinogenic clones of Clostridium difficile from a toxinogenic one.

G Corthier1, M C Muller.   

Abstract

In previous studies, we showed that diet composition or Saccharomyces boulardii ingestion could protect gnotobiotic mice against lethal Clostridium difficile infection. Using an original method, we detected nontoxinogenic clones from feces of protected mice challenged with a toxinogenic clone of C. difficile. These clones became established at the same level as the toxinogenic one after about 30 days. In these protected mice bearing nontoxinogenic clones, no enterotoxin production could be detected and cytotoxin titers were highly reduced. These nontoxinogenic clones were genetically stable because nontoxinogenic clones and clones that produce intermediate levels of toxins in vivo did not revert to toxin production, even after repeated culture in vitro. Furthermore, the nontoxinogenic clones were shown to arise from a single toxinogenic clone and were identical to that clone in metabolic patterns and antibiotic sensitivity tests. When mice fed a nonprotective diet were challenged with a nontoxinogenic or intermediate clone, they remained healthy and no toxin production could be detected in their feces. Moreover, these mice were protected against further infections with toxinogenic strains of C. difficile, and a strong antagonism between nontoxinogenic and toxinogenic clones was observed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3372017      PMCID: PMC259427          DOI: 10.1128/iai.56.6.1500-1504.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Biological activities of toxins A and B of Clostridium difficile.

Authors:  D M Lyerly; D E Lockwood; S H Richardson; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

2.  Purification and characterization of toxins A and B of Clostridium difficile.

Authors:  N M Sullivan; S Pellett; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

3.  Antagonisms among isogenic strains of Escherichia coli in the digestive tracts of gnotobiotic mice.

Authors:  Y Duval-Iflah; P Raibaud; M Rousseau
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

4.  [Rate of isolation of "C. difficile" from stools of hospitalized patients: susceptibility of 75 strains (author's transl)].

Authors:  F Tytgat
Journal:  Ann Microbiol (Paris)       Date:  1980 Jul-Aug

5.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

6.  Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study.

Authors:  P L Stark; A Lee; B D Parsonage
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

7.  Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters.

Authors:  J M Libby; B S Jortner; T D Wilkins
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

8.  Epidemiology of Clostridium difficile in infants.

Authors:  H E Larson; F E Barclay; P Honour; I D Hill
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

9.  [Comparison between the number and nature of fecal clostridia and other risk factors implicated in the intestinal pathology of newborn infants].

Authors:  O Fontaine; R Ducluzeau; P Raibaud; C Chabanet; M R Popoff; J Badoual; J C Gabilan; A Andremont
Journal:  Ann Inst Pasteur Microbiol (1985)       Date:  1986 Jul-Aug

10.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

View more
  7 in total

1.  Heterogeneity of Clostridium difficile isolates from infants.

Authors:  A Collignon; L Ticchi; C Depitre; J Gaudelus; M Delmée; G Corthier
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

Review 2.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

3.  Relationship between levels of Clostridium difficile toxin A and toxin B and cecal lesions in gnotobiotic mice.

Authors:  A Vernet; G Corthier; F Dubos-Ramaré; A L Parodi
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

Review 4.  A clinical and epidemiological review of non-toxigenic Clostridium difficile.

Authors:  Mukil Natarajan; Seth T Walk; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2013-05-29       Impact factor: 3.331

5.  Interrelationships between digestive proteolytic activities and production and quantitation of toxins in pseudomembranous colitis induced by Clostridium difficile in gnotobiotic mice.

Authors:  G Corthier; M C Muller; G W Elmer; F Lucas; F Dubos-Ramaré
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

6.  Identification of toxigenic Clostridium difficile by the polymerase chain reaction.

Authors:  N Kato; C Y Ou; H Kato; S L Bartley; V K Brown; V R Dowell; K Ueno
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

Review 7.  Non-toxigenic Clostridioides (Formerly Clostridium) difficile for Prevention of C. difficile Infection: From Bench to Bedside Back to Bench and Back to Bedside.

Authors:  Dale N Gerding; Susan P Sambol; Stuart Johnson
Journal:  Front Microbiol       Date:  2018-07-26       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.